Lab And Life Instruments Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-07-2024
- Paid Up Capital ₹ 0.10 M
as on 16-07-2024
- Company Age 10 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.02 Cr
as on 16-07-2024
- Revenue 58.85%
(FY 2023)
- Profit 92.08%
(FY 2023)
- Ebitda 71.63%
(FY 2023)
- Net Worth 46.59%
(FY 2023)
- Total Assets -7.75%
(FY 2023)
About Lab And Life Instruments
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.02 Cr.
Deepak Rote, Sadhana Rote, and Amit Nimse serve as directors at the Company.
- CIN/LLPIN
U51101MH2014PTC255438
- Company No.
255438
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Jun 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Navi Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Lab And Life Instruments Private Limited offer?
Lab And Life Instruments Private Limited offers a wide range of products and services, including Autoclaves, Sterilizers & Incubators, Medical Refrigerator Systems, Industrial Furnaces & Ovens, Industrial Ovens, Pumps, Pumping Machines & Spares, Vacuum Pumps, Muffle Furnaces, Dryers & Evaporators, Evaporator, Water Treatment & Purification Plant.
Who are the key members and board of directors at Lab And Life Instruments?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deepak Rote  | Director | 11-Jun-2014 | Current |
| Sadhana Rote | Director | 11-Jun-2014 | Current |
| Amit Nimse | Director | 02-Jun-2022 | Current |
Financial Performance of Lab And Life Instruments.
Lab And Life Instruments Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 58.85% increase. The company also saw a substantial improvement in profitability, with a 92.08% increase in profit. The company's net worth Soared by an impressive increase of 46.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lab And Life Instruments?
In 2023, Lab And Life Instruments had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Yes Bank Limited Creation Date: 18 Jul 2019 | ₹1.02 Cr | Open |
How Many Employees Work at Lab And Life Instruments?
Lab And Life Instruments has a workforce of 17 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lab And Life Instruments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lab And Life Instruments's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
